Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 Aniridia-net.eu – University of Cologne – Webdesign by Effect Group Ltd.

About COST

About COST

Aniridia-net.eu is funded through COST (European Cooperation in Science and Technology). COST is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe. COST aims to enable breakthrough scientific developments leading to new concepts and products, it thereby contributes to strengthening Europe’s research and innovation capacities. COST Actions offers scientists the opportunity to embark upon bottom-up, multidisciplinary and collaborative networks across all science and technology domains.

COST funding is based on Actions, which are networks of coordinated collaborations, to address the specialized issues being set forth by the Action. The Actions are led by a Memorandum of Understanding (MoU) signed by the governments of the COST countries participating in the Action.

COST #CA18116 Mission

Our Action started in April 2019 and will last until April 2023. Currently, 28 countries have joined Aniridia-net.eu.

This Action is led by a Memorandum of Understanding (MoU) signed by the governments of the COST countries participating in the Action.